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In this study, we present integrated quantitative pro-
teome, transcriptome, andmethylomeanalysesofhe-
matopoietic stem cells (HSCs) and four multipotent
progenitor (MPP) populations. From the characteriza-
tion of more than 6,000 proteins, 27,000 transcripts,
and 15,000 differentially methylated regions (DMRs),
we identified coordinated changes associated with
early differentiation steps. DMRs show continuous
gain or loss of methylation during differentiation,
and the overall change in DNAmethylation correlates
inversely with gene expression at key loci. Our data
reveal the differential expression landscape of 493
transcription factors and 682 lncRNAs and highlight
specific expression clusters operating in HSCs. We
also found an unexpectedly dynamic pattern of tran-
script isoform regulation, suggesting a critical regula-
tory role during HSC differentiation, and a cell cycle/
DNA repair signature associated with multipotency
in MPP2 cells. This study provides a comprehensive
genome-wide resource for the functional exploration
of molecular, cellular, and epigenetic regulation at
the top of the hematopoietic hierarchy.
INTRODUCTION
Hematopoietic stem cells (HSCs) are unique in their capacity to
self-renew and replenish the entire blood system (Orkin and
Zon, 2008; Purton and Scadden, 2007; Seita and Weissman,Ce2010;Wilson et al., 2009). They give rise to a series ofmultipotent
progenitors (MPPs) with decreasing self-renewal potential, fol-
lowed by differentiation toward committed progenitors and
more mature cells (Adolfsson et al., 2005; Forsberg et al.,
2006). MPPs have been subdivided immunophenotypically into
MPP1, MPP2, MPP3, and MPP4 populations based on a step-
wise gain of CD34, CD48, and CD135 as well as loss of CD150
expression (Wilson et al., 2008). However, despite recent efforts
to characterize changes in gene expression and epigenome
modifications that occur at distinct stages of differentiation
(Gazit et al., 2013; Kent et al., 2009; McKinney-Freeman et al.,
2012; Bock et al., 2012), the distinct functional characteristics
and the molecular programs that maintain HSC self-renewal
and drive progenitor differentiation are poorly characterized.
We have taken advantage of recent technological advances
enabling analysis of rare cell populations to establish compre-
hensive mass spectrometry-based proteome, transcriptome
(RNA sequencing [RNA-seq]), and genome-wide DNA methyl-
ome (tagmentation-based whole genome bisulfite sequencing,
TWGBS) data for HSCs andMPPs.We provide a comprehensive
insight into the molecular mechanisms that are dynamically
regulated during early HSC commitment through the MPP1–
MPP4 populations.We uncoveredmolecular changes at the pro-
tein, RNA, and DNA levels as they occur in vivo in the context of
physiologic commitment processes.RESULTS
The five stem/progenitor populations corresponding to HSC and
MPP1–MPP4 (Wilson et al., 2008) were isolated by fluorescence-
activated cell sorting (FACS) from the bone marrow of C57BL/6J
mice (Figure 1; Figures S1A–S1C available online). These cellsll Stem Cell 15, 507–522, October 2, 2014 ª2014 Elsevier Inc. 507
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Figure 1. Global Analysis of Early Adult Hematopoiesis
(A) The mouse hematopoietic system. HSCs give rise to MPPs, which commit to more mature progenitors with restricted cell fate. CMP, common myeloid
progenitor; MEP, megakaryocyte erythroid progenitor; GMP, granulocyte macrophage progenitor; CLP, common lymphoid progenitor; Mega, megakaryocyte;
Pla, platelet; Neu, neutrophil; Mac, macrophage; NK, natural killer cell.
(B) FACS scheme used to isolate primary mouse cells: HSC (Linneg Sca-1+ c-Kit+, LSK, CD34- CD135- CD150+ CD48), MPP1 (LSK CD34+ CD135 CD150+
CD48), MPP2 (LSK CD34+ CD135 CD150+ CD48+), MPP3 (LSK CD34+ CD135 CD150 CD48+), and MPP4 (LSK CD34+ CD135+ CD150 CD48+). L,
lineage-negative.
(C) Experimental study design. Shown are the different generated data sets and their respective figure numbers. See also Figures S1 and S7.
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Molecular Landscape of Early Hematopoiesiswere used as a source for quantitative proteomics, RNA-seq,
TWGBS, and functional reconstitution experiments.
Proteome Differences between HSCs and MPP1 Cells
Uncovered Key Molecular Players of Long-Term
Reconstitution Potential
The transition from CD34 HSCs to CD34+ MPP1 is accompa-
nied by a switch in the cells’ reconstitution capabilities.We trans-
planted mice with 50 HSCs and observed that 100% of primary
and 80% of secondary recipients showed multilineage repopu-
lating activity (Figures S1D–S1F). In contrast, 56% of mice trans-
planted with MPP1 cells showed reconstitution of the primary
recipient, and no engraftment was detected in secondary recip-
ients. This is consistent with previous reports showing that the
two populations are very similar but display a measurable differ-
ence in long-term self-renewal (Ema et al., 2006; Osawa et al.,
1996). To investigate the molecular basis of this difference in
self-renewal, we compared the proteomes of HSC and MPP1
cells in a quantitative mass spectrometry-based approach (Fig-
ure 2A; Figure S2A). From 400,000 HSCs and MPP1 purified in
biological triplicate, 6,389 protein groups were identified (Table
S1). These covered a broad range of protein classes, e.g. recep-
tors (222) and transcription factors (549) (Figure 2B), as well as
low-abundance proteins, as judged from the estimated protein
levels that spanned more than seven orders of magnitude
(Figure S2B).508 Cell Stem Cell 15, 507–522, October 2, 2014 ª2014 Elsevier Inc.In total, 4,037 proteins were quantified in all three replicates
(Figure S2C). Of these, only 47 proteins were expressed differen-
tially (false discovery rate [FDR] = 0.1), together with nine pro-
teins detected exclusively inMPP1 (Figure 2C; Figure S2D; Table
S1). This suggests that the differential self-renewal potential be-
tween HSCs and MPP1 is elicited by a relatively small number of
proteins.
Gene ontology (GO) enrichment analysis revealed that cell cy-
cle aswell as related processes, such asDNA replication and cell
proliferation, were strongly overrepresented inMPP1 (Figure 2D).
Indeed, protein-protein interaction network analysis highlighted
a large group of interconnected cell cycle proteins being ex-
pressed at elevated levels inMPP1 comparedwith HSCs. All ma-
jor processes associated with the cell cycle machinery, including
DNA polymerases (Pol1a, Pole), cell cycle checkpoint proteins
(Chek1), DNA methylation maintenance and cell cycle progres-
sion (Cdk1, Cdk6), and others were represented in the network
(Figure 2E). In contrast, HSCswere enriched in themonosaccha-
ride metabolic process, including the glycolytic enzymes lactate
dehydrogenase b and d (Ldhb, Ldhd) as well as Pygm. In addi-
tion, cellular ion homeostasis, including two iron transporters
(Fth1, Ftl2), oxidation reduction (Rrm1, Rrm2), and response to
hypoxia (Mecp2) were enriched in HSCs. Together, the data
are consistent with an anaerobic metabolic program employed
by quiescent HSCs, whereas MPP1 cells become primed for
entry into the cell cycle and start proliferating.
A B
ED
C
Cell lysis/protein extraction/
protein digestion
Peptide labeling
Peptide fractionation
High-resolution nano LC-MS/MS
4x10 cells,
n=3
HSC MPP1
−2
0
2
0.0 0.5 1.0 1.5
−log10(adjusted p−value HSC/MPP1)
lo
g2
 ra
tio
 H
S
C
/M
P
P
1
Gda
Ifitm1
Hmga2
Igf2bp2
Hmga1
Rrm2
Uhrf1
22
25
Cd38
Hmga1
Pygm
Myof
Serpinb6a
Cbr3
Gstm1
Tgm2
Ldhd
Fscn1
Ldhb
Slamf1
Cmas
Gstm5
Irgm2
Nagk
Camk2d
Cdk6
Hells
Plek
Top2a
Serpinb1a
Chek1
Tyms
Dut
Lig1
Ndrg1
Ncaph
Pola1
Hat1
Anxa2
Smc2
Cdk1
Kif2c
Pole
Thy1
Kif4
Gins3
Stmn1 Dnmt1
nucleic acid binding
hydrolase
transferase
enzyme modulator
transcription factor
cytoskeletal protein
oxidoreductase
kinase
ligase
transporter
receptor
membrane traffic protein
signaling molecule
protease
calcium-binding protein
transfer/carrier protein
chaperone
phosphatase
isomerase
lyase
defense/immunity protein
cell adhesion molecule
extracellular matrix protein
structural protein
cell junction protein
tr.membr. rec. reg.
surfactant
storage protein
viral protein
0 500 1000 1500
Protein count
14
8
6
3
4
3
0
5
0
2
5
3
2
1
2
1
0
0
2
1
2
1
1
1
1
1
19
29
7
10
16
14
13
12
9
8
9
4
7
7
20 0 20 40
oxidation reduction
monosaccharide metabolic process
cellular ion homeostasis
regulation of chromosome organization
neuron projection development
response to hypoxia
DNA replication
cell cycle
chromosome condensation
DNA packaging
chromosome organization
cell division
M phase
cellular response to stress
mitosis
cell proliferation
DNA repair
deoxyribonucleotide metabolic process
cell activation
neg. reg. of transcription, DNA-dependent
# proteinsHSC
MPP1
F
-3
-2
-1
0
1
2
lo
g 2
r a
tio
H
SC
/M
PP
1
Dnajc6; Sptlc2; Mtmr9; Zc3h10
Mis12; Mllt1; Faah; Steap3; Ncf4
10.41
Combined score
STRING
Edge color
Average log2 ratio
HSC/MPP1
2 2.7-2
Node fill color Node size
0.10.02
adj. p value
Node shape
Uniquely
detected
MPP1
Gstm1
Hmga2
Ncf4
Hmga1
Gstm5
Smc2
Top2a
Tyms
Rrm2
Chek1
Pygm
Ncaph
Kif4
Mis12
Stmn1
Kif2c
Ldhb
Gins3
Ldhd
Cdk1
Lig1
Uhrf1
Pole
Hells
Dnmt1
Plek
Pola1
Dut
Cdk6
Hat1
+9
5
Figure 2. Proteomic Comparison of HSCs and MPP1
(A) Quantitative proteomics workflow.
(B) Classification of identified proteins. Bars show the number of proteins within each functional class.
(C) Differential protein expression. Proteins expressed significantly higher (FDR = 0.1) in HSCs andMPP1 are shown in red and blue, respectively. The lower right
corner shows proteins exclusively detected in MPP1.
(D) Overrepresented biological processes of differentially expressed proteins (202 with FDR = 0.15 and 9 exclusively detected in MPP1). Top, HSC-enriched.
Bottom, MPP1-enriched. Neg. reg. of transcription, negative regulation of transcription.
(E) Protein network of differentially expressed proteins. The edges show known and predicted protein-protein interactions. STRING, Search Tool for the Retrieval
of Interacting Genes/Proteins; adj., adjusted.
(F) CD cell surface proteins expressed differentially. The average log2 ratio ± SD is shown.
See also Figure S2.
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Molecular Landscape of Early HematopoiesisOf the 22 proteins with higher expression in HSCs, we found
three highmobility group AT hook proteins; namely, two isoforms
of Hmga1 as well as Hmga2 (Figure 2C; Figure S2E). These chro-
matin-modulating transcriptional regulators have been reported
recently to be potent rheostats of tumor progression (Morishita
et al., 2013;Shahet al., 2013) andHSCself-renewal, proliferation,
and lineage commitment checkpoints (Battista et al., 2003; Cop-
ley et al., 2013). In addition, the protein showing the highest fold
change was the Hmga2 target Igf2bp2 (Figure 2C; Cleynen
et al., 2007). Hmga1, Hmga2, and Igf2bp2 are downstreammedi-
ators of the Lin28-let7 pathway that link metabolism to prolifera-Cetion and drive self-renewal (Shyh-Chang et al., 2013; Yaniv and
Yisraeli, 2002).Highexpressionof this pathway inHSCssuggests
a role in self-renewal of HSCs, whereas its downregulation in
MPP1 cells correlates with decreasing self-renewal activity.
Two glutathione S-transferases (GST), Gstm1 and Gstm5,
were found to be expressed at higher levels in HSCs compared
to MPP1 (Figure 2C). Moreover, elevated levels in HSCs were
consistent for all 11 GSTs quantified (Figure S2F). This points
to a requirement for this enzyme class in HSCs, whichmay relate
to their ability to mediate the conjugation of xenobiotics for the
purpose of detoxification and defense against environmentalll Stem Cell 15, 507–522, October 2, 2014 ª2014 Elsevier Inc. 509
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Molecular Landscape of Early Hematopoiesisstress and cellular damage (Tew and Townsend, 2012). This sug-
gests that homeostatic HSCs have an array of mechanisms in
place to protect their cellular integrity, extending an observation
that we have made previously in hematopoietic progenitors
(Klimmeck et al., 2012). Along these lines, two interferon-induc-
ible proteins involved in host defense (Ifitm1 and Irgm2) were
expressed at higher levels in HSCs compared with MPP1 (Fig-
ure 2C), suggesting that the type I interferon pathway is not
only critical for the response to stress but also during homeosta-
sis (Essers et al., 2009; Trumpp et al., 2010). Moreover, HSCs
and MPP1 employ different intracellular serpins for protection
against death during stress because Serpinb6a and Serpinb1a
were expressed at higher levels in either HSC or MPP1, respec-
tively (Figure 2C). Taken together, HSCs harbor proteins involved
in immune defense and detoxification, indicative of an increased
self-protecting repertoire compared with MPP1.
Among the 86 quantified cluster of differentiation (CD) surface
proteins (Table S1), nine showed a strong differential expression
between HSC and MPP1 (Figure 2F). These included CD34 as
well as other membrane proteins described previously in the
context of stem/progenitors, namely CD38, CD41, CD49b, and
CD90 (Benveniste et al., 2010; Dumon et al., 2012; Weissman
and Shizuru, 2008). Additionally, our analysis identified CD82
and CD13 to be expressed at higher levels in HSCs, whereas
CD11b had a higher expression level in MPP1. These findings
may be used to develop additional marker combinations to
distinguish HSCs and MPP1 as well as to further refine the clas-
sification of stem/progenitor intermediates.
The Transcriptome and Proteome Are Highly
Coordinated upon HSC Differentiation
We next analyzed the transcriptome of HSCs and MPP1 using
high-throughput RNA sequencing starting from 30,000 FACS-
sorted primary cells (Figure 3A; Figure S3A). Robust and repro-
ducible data were obtained for all samples, with more than 2 3
108 total readings per population (Figure S3B). In total, tran-
scripts corresponding to 27,881 genes were identified (Table
S2). Those genes were classified, according to their database
annotation, into 21 RNA categories, and, as expected, protein-
coding transcripts were highly represented (68.9%) (19,219;
Figure 3B). In line with the proteome data, the protein-coding
transcripts displayed a high diversity of functionalities (Fig-
ure 3C), including transcription factors (TF, 1,776 genes), recep-
tors (1,796), and cell adhesion molecules (584). Additionally, the
expression of 8,662 noncoding RNA species was identified,
including pseudogenes (4,034), microRNAs (miRNAs) (642) and
long noncoding RNAs (lncRNAs) (589).
We found 479 genes to be expressed differentially between
HSCs and MPP1 (FDR = 0.1; Table S2; Figure 3D). Consistent
with the GO terms enriched in the proteome data, we found
an overrepresentation of processes related to metabolism (pos-
itive regulation of the phosphate metabolic process and sulfur
compound metabolic process) and response to hypoxia (cellular
response to oxygen-containing compounds) within the genes
expressed at higher levels in HSCs (Figure 3E). Furthermore,
TFs involved in different aspects of developmental signaling
(cellular developmental process, cell differentiation Mecom,
Hoxb7) were enriched in HSCs. In contrast, the DNA metabolic
process, cell cycle, and nuclear division were enriched in510 Cell Stem Cell 15, 507–522, October 2, 2014 ª2014 Elsevier Inc.MPP1 in agreement with the proteome findings and increasing
proliferative activity.
To systematically investigate potential posttranscriptional
regulation at the transition from HSCs to MPP1, we correlated
the transcriptome data with the proteome data (Figures 3F–3G;
Table S3). Out of the quantified proteins, we were able to assign
99.3% (4,007 of 4,036) to their corresponding transcripts (Fig-
ure 3F; Figures S3D–S3E). Notably, in addition to a strong positive
correlation between both data sets, all proteins that were ex-
presseddifferentiallywerealsoconsistently upregulatedordown-
regulated at the transcript level (Figure 3F). For example, the
response to cytokine stimulus was overrepresented at both the
RNA and protein levels in HSCs, whereas genes belonging to
the cell cycle and DNA replication were expressed strongly in
MPP1 (Figure 3G). As a notable exception to this overall pattern,
enzymes in glycolysis/gluconeogenesis (Cmas, Gstm5, and
Nagk), as well as several downstream targets of the Lin28-let7
pathway (Hmga1, Hmga2, and Igf2bp2), showed only modest
changes at the mRNA level (Figures 3F and 3G), in line with their
suggested regulationat theposttranscriptional level (Shyh-Chang
andDaley, 2013). In addition, we found theGO termchromosome
enriched and several long-lived histones related to chromosome
organization (e.g. H2afz, H2afy2) to be downregulated at the
RNA level inMPP1.Because thesewerenotdetectedasbeingex-
pressed differentially at the protein level (Figures 3F and 3G), we
hypothesize that the regulatory initiation of nuclear reorganization
starts already in MPP1 but becomes only operational at subse-
quent stages. The overall high similarity between the transcrip-
tome and proteome suggests that posttranscriptional regulation
in HSC/progenitors might be used preferentially only for some
pathways, including the Lin28-Hmga-Igf2bp2 axis.
MPP2 Cells Are Multipotent, but MPP3 and MPP4 Show
a Differentiation Lineage Bias
To investigate the functional attributes of MPP2–MPP4, we per-
formed in vivo reconstitution assays using FACS-sorted cells
(Figure 4A; Figures S4A–S4B). The contribution of transplanted
MPP2 cells to the T cell, B cell, andmyeloid progeny in peripheral
blood (PB) after 4 months was 23%, 35%, and 32%, respec-
tively, compared with the 56%, 70%, and 82% observed for
transplanted HSCs (Figures 4B and 4C; Figure S4A). In contrast,
MPP3 and MPP4 cells generated only a small number of differ-
entiated cells (mostly below 2%), although the progeny were re-
tained in the PB for at least 4 months. MPP3-transplanted mice
showed a bias toward the production of myeloid cells, which
was evident from 1 week posttransplantation but decreased
over time. MPP4-transplanted animals preferentially generated
lymphoid B cell progeny starting at 3 weeks posttransplantation,
whereas myeloid progeny remained below 1% during the entire
observation period. In line with this, T cells peaked after 3 weeks
in the thymi of MPP4-transplantedmice (Figure S4B). In addition,
colony-forming unit (CFU) assays showed that, like MPP2 and
MPP3 progenitors, MPP4 cells also generate myeloid colonies
(Figure S4C), in line with earlier studies performed with
CD135+ lymphoid-primed multipotent progenitors (Adolfsson
et al., 2005). In summary, MPP2 generates a large number of
long-term myeloid, B cell, and T cell progeny upon transplanta-
tion. In contrast, the other two populations generate only a
limited number of progeny in vivo, with a significant lineage
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Figure 3. Comparison of the Transcriptome and Proteome of HSCs and MPP1 Cells
(A) RNA-seq workflow.
(B) RNA categories of 27,881 quantified genes. Shown are the percentage and number of RNA species within each RNA class.
(C)Classification of quantifiedprotein-codinggenes.Bars show the number of geneswithin each functional class, rankedbasedon theprotein coverage (Figure 2B).
(D) Differential gene expression. Genes highly expressed (FDR = 0.1) in HSCs or MPP1 are shown in red and blue, respectively.
(E) Overrepresented biological processes of differentially expressed genes.
(F) Overlap and correlation between protein and RNA expression changes. Top panel, integration of proteome and transcriptome data sets. Quantified proteins
(blue) were mapped to protein-coding transcripts (green). Differentially expressed transcripts (dark green, 78 mapped of 435) and differentially expressed
proteins (dark blue, 47 significant plus 9 exclusively detected proteins) were assessed for overlap (red). Bottom panel, significant (FDR = 0.1) changes at RNA
(green), protein (blue), and both levels (red, correlation coefficient R = 0.93), respectively. The box on the left indicates exclusively detected proteins.
(G) 2D GO enrichment analysis of protein and RNA expression changes. Red regions correspond to concordant enrichment or lower expression. Blue and green
regions highlight terms that are enriched or lower in one direction but not in the other, whereas terms in yellow regions show anticorrelating behavior. GOBP, gene
ontology biological process; GOCC, gene ontology cellular compartment; KEGG, Kyoto Encyclopedia of Genes and Genomes.
See also Figure S3.
Cell Stem Cell
Molecular Landscape of Early Hematopoiesis
Cell Stem Cell 15, 507–522, October 2, 2014 ª2014 Elsevier Inc. 511
Weeks
B
C
1 3 6 9 12 16
0.01
0.10
1
10
100
MPP2
1 3 6 9 12 16
0.01
0.10
1
10
100
MPP3 MPP4
3 9 126 16 3 9 126 161 1
MPP4
MPP2
MPP3
B-cells
My-cells
T-cells
B-cells
My-cells
T-cells
1 3 6 9 12 16
0.01
0.10
1
10
100
D
on
or
C
D
45
.2
(%
)
D
CD34
CD48
CD150
CD135
m
ea
n
R
N
A
ex
pr
es
si
on
MPP4HSC MPP2MPP1 MPP3
A
G
3,240
2,437
1,797
479
1,040
3,826
4,288
1,436
4,043
3,721
MPP4
MPP3
MPP2
HS C MPP1
F
J
L
0 0.2
ex
tra
ce
llu
lar
 re
gio
n
ce
ll a
dh
es
ion
res
po
ns
e t
o w
ou
nd
ing
inf
lam
ma
tor
y r
es
po
ns
e
ce
ll c
om
mu
nic
ati
on
de
ve
lop
me
nta
l p
roc
es
s
ce
ll p
rol
ife
rat
ion
res
po
ns
e t
o s
tim
ulu
s
ce
ll s
urf
ac
e r
ec
ep
tor
 si
gn
ali
ng
 pa
thw
ay
ce
ll m
igr
ati
on
ve
sic
le
me
tab
oli
c p
roc
es
s
ch
rom
os
om
e o
rga
niz
ati
on
nu
cle
os
om
e
cy
tos
ke
let
on
 or
ga
niz
ati
on
ce
ll d
ivis
ion
ch
rom
os
om
e, 
ce
ntr
om
eri
c r
eg
ion
DN
A r
ep
air
DN
A r
ep
lica
tio
n
cy
tok
ine
 pr
od
uc
tio
n
lym
ph
oc
yte
 m
ed
iat
ed
 im
mu
nit
y
de
fen
se
 re
sp
on
se
 to
 ba
cte
riu
m
T c
ell
 di
ffe
ren
tia
tio
n
leu
ko
cy
te 
ch
em
ota
xis
B c
ell
 di
ffe
ren
tia
tio
n
int
erl
eu
kin
−6
 pr
od
uc
tio
n
res
pir
ato
ry 
sy
ste
m 
de
ve
lop
me
nt
em
bry
on
ic 
for
eli
mb
 m
orp
ho
ge
ne
sis
ca
no
nic
al 
Wn
t re
ce
pto
r s
ign
ali
ng
 pa
thw
ay
ne
rve
 de
ve
lop
me
nt
me
lan
os
om
e o
rga
niz
ati
on
int
erl
eu
kin
−1
 pr
od
uc
tio
n
res
po
ns
e t
o i
nte
rfe
ron
−b
eta
en
do
cy
tos
is
pro
tei
n s
ec
ret
ion
JA
K−
ST
AT
 ca
sc
ad
e
pre
−B
 ce
ll d
iffe
ren
tia
tio
n
co
ag
ula
tio
n
pla
tel
et 
ac
tiva
tio
n
ca
lciu
m 
ion
 ho
me
os
tas
is
reg
ula
tio
n o
f p
rot
eo
lys
is
po
sit
ive
 re
gu
lat
ion
 of
 R
NA
 m
eta
bo
lic 
pro
ce
ss
ne
uro
ge
ne
sis
ER
K1
 an
d E
RK
2 c
as
ca
de
MA
PK
 ca
sc
ad
e
kin
as
e a
cti
vit
y
ph
os
ph
ory
lat
ion
lip
id 
bin
din
g
int
erf
ero
n−
ga
mm
a p
rod
uc
tio
n
my
elo
id 
leu
ko
cy
te 
dif
fer
en
tia
tio
n
30 51 9 47 67 41 33 35 21
48 77 313 52 63 536 77 24 48 17 45 32 16 10 19 15 10
53 70 7 19
49 38 47 36 157 149 53 235 76 35 38 10 12 18 12 7 22 21 8 3 39 10 13
46 4 3
18 16 76 73 118 39 18 6 27 7 22 29 6
5
18 18 6 13 9
17 13 16 7 6
56 38 45 22 135 136 48 201 67 32 35 15 9 24 11 18 12 8 21 37 5 10
12 7
103 62 51 301 338 113 414 152 70 24 8 82 87 47
14 5 3
35 84 86 115 40 5 4
1
adjusted p-value
HSC (#2)
MPP1 (#3)
HSC-MPP1 (#4)
MPP1-MPP2 (#7)
HSC-MPP1-MPP2 (#8)
MPP2-MPP3 (#13)
MPP1-MPP2-MPP3 (#15)
HSC-MPP1-MPP2-MPP3 (#16)
HSC-MPP4 (#18)
HSC-MPP1-MPP4 (#20)
MPP3-MPP4 (#25)
HSC-MPP3-MPP4 (#26)
MPP2-MPP3-MPP4 (#29)
MPP1-MPP2-MPP3-MPP4 (#31)
1
Fanca
Rad51ap1
Smc2
Pola1
Trp53
Polh
Ssr p1
Dna2
Pcna
Ruvbl1 Eef1e1
Exo1
Fanci
Li g1
Clspn
Hmgb2
Smc4
Pif1
Rad9
Kif22
Rad54l
Chek1
Chaf1a
Smc1a
Smarc b1
Nsmc e1
Polq
Neil3
Uhrf1
Foxm1
Cdca5
Trip 13
Nsmc e2
Uchl5
Bar d1
Dt l
Act l6a
Pole
Nono
Hus1b
Cul4a
Dek
Baz1b
Nud t1
Ogg
Ube2a
Pol d3
Faap24
Mbd4
Fancd2 Rad50
Rad52 Rpa1
Topb p1
Br ip1
Rad54b
Btbd 12
LOC677447
Eme1
Erc c1
Msh6
Mcm8
H2afx
Emsy
Gm15428
Rad18
Rad51
Rad51c
Fancb
Brc a1
Xrc c3Mus81
Rtel1
Rbb p8
Api td1
Rpa2
Paxip1
10.4
Combined score
STRING
Edge color Node size
561
Degrees
Node color
MPP1 MPP2 MPP3 MPP4
Highest expression
M
C
D
45
.1
 
Read-out 
PB, BM, SPL & THY 
MY-cells LY-cells 
CD45.2 
CD45.1/2  
Supportive 
CD45.2 B6J  
Donor 
MPP2 
MPP3
MPP4 
1 -16 weeks 
CD45.1
Recipient  
E
-3
-2
-1
0
1
2
3
0
2
-1
1
2
-2
1
0
-1
H
Retinoic acid
metabolic processMitosis
B cell receptor
signaling pathway
M
ea
n 
lo
g2
 fo
ld
 c
ha
ng
e 
HSC
MPP1
MPP2
MPP3
MPP4
P
C
2
40
20
0
-20
-40
PC 1
-40 -20 0 20 40
−3 −1 1 3
Row Z-score
0
80
0
C
ou
nt
HSC MPP1 MPP2 MPP3 MPP4 
HSC
MPP1
MPP2
MPP3
MPP4
I
Car1
Thpo
Lmna
Rgs10
Mrvi1
F2r
Gp5
Hemgn
Gata1
Itga2b
Klf1
Gstt1
Gpr64
Clu
Cmas
Tspan33
Zfpm1
Epor
Gata2
Nckap1
vWF
Pdzk1ip1
Mpl
Fli1
Fhl1
Aldh1a1
Bpgm
Tal1
Aqp1
Gp1bb
Sdpr
Htatip2
Gadd45a
Il1rl1
Cpa3
Selp
Itgax
Cd96
Igtp
Ctla2b
H2−Aa
Ldhb
H 1 2 3 4
−3 0 3
Row Z-score
x0.1
x1
Fold change
x0.0003
Enriched
Non-enriched
H
SC
M
PP
1
M
PP
2
M
PP
3
M
PP
4
N
ge
ne
s
C
lu
st
er
N
G
O
s
1 0 0
2 390 60
3 54 10
4 1484 247
5 27 0
6 86 0
7 155 16
8 497 431
9 36 0
10 57 0
11 20 0
12 22 0
13 204 50
14 28 0
15 178 57
16 17 4
17 84 0
18 340 261
19 25 0
20 170 47
21 39 0
22 14 0
23 42 0
24 3 0
25 709 324
26 227 41
27 58 0
28 4 0
29 1176 306
30 11 0
31 330 306
32 0 0
K
Regulation of metabolism
* *
**
*
** **
*
*
***
*
*
*
*
***
*
*
*
Lin28b*
Lin28a* Igf2*
Foxa3*
Igf2bp2*
Hmgb2* Hmga2*
Hmga1
Insr Igf1* Hif1a
Insrr* Hif3a*
Irs2* Igf2r*
Retinoic acid metabolism
* *
*
* * *
*
* *
* *
*
*
*
Retinoic acid metabolic process
RAR / PPAR signaling
*
*
* *
*
* * * *
* * *
*
*
*
Aldh1a1* Bco2* Rbp1* Cyp26b1*
Rdh10* Rdh5* Rxra
Aldh1a7* Aldh1a3 Crabp2 Cyp26a1
Rara* Rarb* Rarg*
Adh1 Aldh1a2*
Pparg Ppard* Ppargc1a*
M
ea
n
ex
pr
es
si
on
H
SC
M
PP
1
M
PP
2
M
PP
3
M
PP
4
* RNA DEG HSC-MPPs FDR=0.1
* * * RNA DEG HSC/MPP1,2,3 or 4   
Proteome DEP HSC/MPP1
Ldhb: RNA mean expression >700
Ldhc: RNA mean expression <700
Ldhb*
Lin28b
Let7
Igf2bp2; Hmga1; Hmga2
 Insr; Igf1; Igf2; Igf2r
Anaerobic
Glycolysis
OxPhos; TCA
Proliferation
FDR=0.1
FDR=0.1
Fancc
Kat5
lh1M
(legend on next page)
Cell Stem Cell
Molecular Landscape of Early Hematopoiesis
512 Cell Stem Cell 15, 507–522, October 2, 2014 ª2014 Elsevier Inc.
Cell Stem Cell
Molecular Landscape of Early Hematopoiesisbias toward mostly myeloid (MPP3) or lymphoid (MPP4) cell
types.
Clustering Analyses Identify Global Molecular
Differences during HSC Differentiation
We sequenced the transcriptomes of the MPP2, MPP3, and
MPP4 populations in biological triplicates (Figures 4D–4M; Fig-
ures S4D–S4G). The surface markers used for FACS showed
consistency between transcript and protein levels (Figure 4D).
We detected 6,487 genes to be expressed differentially across
all five populations (FDR = 0.1; Table S2). The differential expres-
sion of a set of genes was confirmed by quantitative real-time
PCR (Figure S3F), validating the robustness of the data. Unsu-
pervised clustering of gene expression profiles grouped together
HSC andMPP1 as well as MPP3 andMPP4 (Figure 4E). This was
verified by principal component analysis (Figure 4F) and by the
numbers of differentially expressed genes in each pairwise com-
parison (Figure 4G). In all analyses, MPP2 was placed between
the HSC-MPP1 and MPP3-MPP4 clusters (Figures 4B and C;
Figures S4A and S4B).
Clustering of Gene Expression Profiles Suggests
Processes Operating in HSC/MPP1-MPP4 Cells
The 6,487 genes with differential expression across the five
cell populations were enriched in specific GO terms (http://
www-huber.embl.de/SMHSC/HSCGO/goAnalysis.html; Sup-
plemental Information), of which we highlight three selected
examples (Figure 4H). Based on the expression data, MPP2 is
the mitotically most active population, whereas HSC is the
most quiescent one. In agreement with the functional lymphoid
differentiation bias observed in MPP4-transplanted recipients
(Figures 4B and 4C), the B cell receptor signaling pathway was
enriched in this population. Consistent with this, mapping
of the HSC-MPP data against granulocyte macrophage or
lymphoid-primed progenitor signatures described previously re-
vealed an enrichment for MPP3 and MPP4 populations, respec-
tively (Ma˚nsson et al., 2007; Figure S4E). In addition, genes of aFigure 4. Lineage Potential and Whole Transcriptome Molecular Signa
(A) Experimental workflow for investigation of the in vivo reconstitution potential. M
myeloid (MY) and lymphoid (LY) outcomes were monitored over time by flow cyt
(B and C) Monitoring the myeloid and lymphoid outcomes in peripheral blood afte
contribution (C) of donor myeloid (blue), B cells (gray), and T cells (purple) were m
animals at 1–16 weeks. n = 8-12 per group. The sizes of the circles in the right p
(D) Differential RNA expression of the surface markers used for FACS. Average R
(E) Clustered heat map. The colors represent the normalized average read co
(FDR = 0.1).
(F) Principal component analysis.
(G) Relative distances are shown based on numbers of differentially expressed g
(H) GO enrichment analysis of 6,387 genes with differential expression. Three rep
shown.
(I) Expression of megakaryocytic/erythrocytic genes.
(J) Transcriptome and proteome signatures of metabolism. Average RNA exp
peroxisome proliferator-activated receptor; OxPhos, oxidative phosphorylation;
(K) Gene expression clusters. 6,487 differentially expressed genes were grouped
population(s) compared with mean expression level across all cell populations.
(L) Representative overrepresented GO terms of gene expression clusters. The nu
(FDR = 0.1).
(M) Network of HSC-suppressed DNA repair genes. Genes with low expressio
interactions are shown. The colors depict the MPP population with the highest e
See also Figure S4.
Cemegakaryocytic erythroid signature described previously
(Ma˚nsson et al., 2007; Gekas and Graf, 2013; Sanjuan-Pla
et al., 2013) were expressed preferentially in HSCs, MPP1, and
MPP2 compared with MPP3 and MPP4 (Figure 4I).
Consistent with the differential expression of metabolic en-
zymes between HSCs and MPP1 (Figures 2D and 3E), we found
genes belonging to the retinoic acid metabolic process to be
highly expressed in HSCs compared with all other populations
(Figures4Hand4J), suggesting a role in adult HSCs. Furthermore,
we found evidence for stage-dependent and isoform-specific
expression of essential glycolytic enzymes in HSCs (e.g. Aldoc,
Ldhb; Figure S4D), extending recent studies demonstrating the
relevance of anaerobic glucose metabolism for the maintenance
of HSC self-renewal (Takubo et al., 2013). In contrast, the large
majority of enzymes involved in the tricarboxylic acid cycle and
oxidative phosphorylation showed MPP2-enriched expression
(e.g. Fh1, Aco2). Interestingly, although Lin28b and its target
genes, including Hmga2 and Igf2bp2, were highly expressed in
HSCs compared with MPP1, the family member Lin28awas spe-
cifically upregulated in MPP3 (Figure 4J). Therefore, our findings
support the recently established role of the Lin28-let7 axis in
glucose metabolism in stem cells (Shyh-Chang and Daley, 2013)
and suggestLin28b asa candidate for anupstreamposttranscrip-
tional regulator of glycolytic enzymes inHSCs (Figures3Fand3G).
Next we assigned each of the 6,487 differentially expressed
genes to one of the 32 possible relative expression patterns (Fig-
ure 4K) and tested for overrepresented GO terms within each
pattern (Table S4). Population-specific GO terms are displayed
in Figure 4L. Consistent with the strong upregulation of cell
cycle-associated genes in MPP2, we observed that 43% of the
genes involved in DNA repair also showed the highest expres-
sion in MPP2 (Figure S4F). The protein-protein interaction
network of the HSC-suppressed DNA repair genes comprised,
e.g., Brca1 and Exo1 (Figure 4M), representing potential players
for the switch in DNA repair mechanisms between HSCs and
MPP2. Interestingly, the two common mechanisms for repair of
DNA double strand breaks (homologous recombination andtures of HSC-MPP1-4 Populations
PP2, MPP3, and MPP4 were transplanted into lethally irradiated mice, and the
ometry. SPL, spleen; THY, thymus.
r transplantation of MPP2, MPP3, and MPP4. The relative percentage (B) and
onitored from the peripheral blood of MPP2-, MPP3-, and MPP4-transplanted
lot represent fold change relative to HSC contribution after 3 weeks.
NA expression ± SD is shown.
unt in each of the five cell populations for all differentially expressed genes
enes in pairwise comparisons.
resentative examples of significantly enriched GO terms out of 1,001 terms are
ression ± SD is shown (arbitrary units). RAR, retinoic acid receptor; PPAR,
DEG, differentially expressed genes.
into 32 clusters based on higher expression (enriched) in one or several cell
mber of genes within each cluster is shown for significantly enriched GO terms
n in HSCs (Z-score < 1.5) and with known and predicted protein-protein
xpression. Note that most genes are most highly expressed in MPP2.
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Figure 5. Gene Expression Signatures and Transcript Isoform Regulation in HSCs and MPP1–MPP4 Cells
(A) Signaling pathway enrichment analysis. Shown is the overrepresentation of signaling pathways within HSC- and HSC-MPP1 clusters. NOVA, neuro-
oncological ventral antigen; ACE, angiotensin-converting enzyme.
(B) Wnt signaling. Shown is a pathway analysis based on WikiPathways (WP403). Average RNA expression ± SD is shown (arbitrary units).
(C) Association of differentially spliced genes to protein classes.
(D) Representative example for a TF (Foxj3) showing differential exon use. The first Foxj3 exon was detected at higher levels in HSC (red) compared with
MPP1 (blue).
Cell Stem Cell
Molecular Landscape of Early Hematopoiesisnonhomologous end joining) also showed a different expression
pattern across the five cell populations. Both repair processes
are low in HSCs and are most enriched in MPP2 (Figure S4G).
In summary, our data indicate that the increased mitotic activity
during HSC differentiation, starting in MPP1 and peaking in
MPP2, is associated with a parallel increase in expression of
DNA repair pathway genes.514 Cell Stem Cell 15, 507–522, October 2, 2014 ª2014 Elsevier Inc.To investigate the signaling pathway complexity of both the
HSC and the HSC-MPP1 self-renewal clusters, we tested for
overrepresentation of differentially expressed genes in pathways
annotated in REACTOMEwithin each group of genes. We found,
among others, G protein-coupled receptor (Gpr143, Pde1c)
and transforming growth factor b (Inhba, Bmp4) signaling to
be enriched (Figure 5A; Table S4). In accordance with the GO
Cell Stem Cell
Molecular Landscape of Early Hematopoiesisenrichments (Figure 4L), Wnt signaling was prominent in self-
renewing HSCs and MPP1. Although the role of canonical
b -catenin-mediated Wnt signaling in adult HSCs remains
controversial (Koch et al., 2008; Luis et al., 2012), noncanonical
signaling has recently been suggested to mediate critical inter-
actions between HSCs and their niches (Sugimura et al., 2012).
Therefore, we interrogated individual expression patterns of
the entire Wnt signaling pathway during differentiation of HSCs
toward MPP4. Although the pathway was highly overrepre-
sented in HSC-MPP1, none of the Wnt ligands were expressed
at high levels, arguing against autocrine production of Wnt
ligands (Figure 5B). However, even low levels ofWnt ligands sup-
port stem cell self-renewal (Luis et al., 2012). In agreement with
this, three frizzled receptors (Fzd4, Fzd8, and Fzd9) were highly
expressed in HSC-MPP1, consistent with reported Fzd4 expres-
sion in humanCD34+ cells (Tickenbrock et al., 2008) and a role of
noncanonical Fzd8 in the maintenance of quiescent long-term
HSCs (Sugimura et al., 2012). Taken together, our analysis un-
derscores the relevance of Wnt signaling for HSCs but also out-
lines the complex isoform-specific enzyme utilization operational
in HSCs and the different MPPs. This likely contributes to the dy-
namic regulation of this pathway, which is critical for most stem/
progenitor cell types.
Transcription Factor and Transcript Isoform Regulatory
Landscape
Among the genes expressed differentially across the five popu-
lations, we identified 490 TFs, including members of the Fox,
Gata, and Hox families (Table S2). TF splice isoforms can have
stage- and tissue-specific expression patterns throughout
development (Lo´pez, 1995; Sebastian et al., 2013) and alterna-
tive splicing has been shown to trigger switches between acti-
vating and repressive TF isoforms (Taneri et al., 2004). We tested
for differential exon use for detection of alternative transcription
start sites, alternative splicing, and alternative terminations sites
(Anders et al., 2012) in the HSC MPP1–MPP4 transcriptome
data. Among the 497 genes expressing transcript isoform vari-
ants across HSC MPPs (FDR = 0.1), we identified 46 TFs (Fig-
ure 5C; http://www-huber.embl.de/SMHSC/HSCDEU/overall/
testForDEU.html; Supplemental Information). We observed that
the first exon of the TF forkhead box J3, Foxj3, was included
more frequently in the HSC transcripts compared with MPP1,
suggesting the expression of a specific Foxj3 isoform in HSCs
(Figure 5D). Although the role of this Foxj3 variant in hematopoi-
esis is uncharacterized, an alternative splicing switch for another
forkhead family member, Foxp1, has recently been shown to
regulate embryonic stem cell pluripotency and reprogramming
by changing its DNA-binding preference (Gabut et al., 2011).
Genome-wide DNA Methylation Analysis of HSCs/MPPs
Identifies Candidate Regions for Epigenetic Regulation
To investigate the methylation status of all cytosine residues
within the genome of HSCs and MPPs, we subjected R10,000
FACS-sorted cells per biological replicate to TWGBS (Wang
et al., 2013) (Figure 6A; Figure S5A). Robust data were obtained
for all samples, with more than 6 3 108 reads and a combined
genomic cytosine-phosphate-guanine (CpG) coverage of more
than 33-fold per population across the three biological replicates
(Figure S5B). Global levels of DNA methylation ranged betweenCe81% and 83% and were not significantly different across popu-
lations, whereas pairwise comparisons identified a total
of 15,887 distinct differentially methylated regions (DMRs)
(Figure 6B; Table S5). Mapping these DMRs to previous DNA
methylome data generated on HSC/MPPs using reduced repre-
sentation bisulfite sequencing (RRBS) (Bock et al., 2012), we
found that 85% of all DMRs were exclusively identified using
the TWGBS analysis (e.g. Mecom; Figure S5C), demonstrating
the additional coverage of our data set. Early commitment steps
correlated with lower numbers of DMRs (1,121, HSC-MPP1),
which likely reflects close ontogenic and functional relationships,
and were mainly associated with loss of methylation (71%, HSC-
MPP1). In contrast, transitions betweenmore differentiatedMPP
populations showed higher numbers of DMRs (1,874, MPP2-
MPP3/MPP4) and gain of methylation (75%, MPP2-MPP3/
MPP4; Figure 6C; Figure S5D; Table S5). Globally, methylation
changes showed continuous progressive behavior (gain or
loss) through HSC differentiation (Figure 6C).
Next we investigated the overlap of DMRs with annotated
genomic features derived from Refseq (Figure 6D; Pruitt et al.,
2009). The majority of DMRs were located in intragenic regions
(57%), whereas promoters and intergenic regions comprised
9% and 34%, respectively. Comparison of our data set with
experimentally defined functional genomic elements (Stama-
toyannopoulos et al., 2012; Shen et al., 2012) demonstrated a
significant overrepresentation of DNaseI hypersensitivity sites
(DHSs), promoters, enhancers, and/or transcription factor bind-
ing sites (TFBSs) across DMRs (Figure S5E; all p values < 1016).
Interestingly, 74% of all DMRs that overlapped with DHSs
(10,887) mapped to regions annotated as TFBSs, promoters,
and/or enhancers, suggesting that dynamic methylation upon
hematopoietic commitment occurs predominantly at cis-regula-
tory elements (Figure 6E). Together, these data support the
hypothesis that many DMRs represent cis-regulatory elements
in HSC-MPPs.
Gene Expression Anticorrelates Globally with Changes
in DNA Methylation
Given the significant overlap between DMRs and functionally
important regulatory regions of the genome, we postulated
that the methylation changes could be associated with gene
expression during HSC differentiation. Indeed, we found that
DMRs coincided with previously identified cis-acting regulatory
sites at the Sfpi1 (Rosenbauer et al., 2004) and Gata2 (Gao
et al., 2013) loci (Figure S5F), which both encode TFs described
as effectors of hematopoietic commitment. We generated gene
sets based on DMRs that were stratified for methylation increase
or decrease and interrogated the associated gene expression
levels between HSCs and each of the MPP populations. DMRs
detected at the early transition of HSC to MPP1 were signifi-
cantly associated with anticorrelated gene expression along
differentiation (Figure 6F). In addition, pairwise comparisons
demonstrated a global anticorrelation between transcription
and DNA methylation (Figure 6G; Supplemental Information).
Among the top anticorrelating genes between HSC-MPP1 (80;
Table S6), we found a number of well documented markers
of early hematopoietic differentiation and HSC function (e.g.
Hoxb2, Rorc, Cd34). For example, the increasing expression
of Cd34 and Wnt-inhibitory factor (Wif1) from HSC to MPP1 isll Stem Cell 15, 507–522, October 2, 2014 ª2014 Elsevier Inc. 515
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Figure 6. Global DNA Methylation Analysis and Anticorrelation with Gene Expression
(A) DNA methylome workflow.
(B) Gain or loss of methylation DMRs between HSC-MPPs. The numbers indicate total DMRs.
(C) Clustering of DMRs identified between HSC-MPP1 or MPP2-MPP3/MPP4. Each horizontal dash represents a DMR. R1–R3, replicates 1–3.
(D) Overlap of DMRs with gene-centric Refseq genomic regions.
(E) Percent overlap of all DMRs with experimentally defined functional genomic elements based on available data from the mouse ENCODE project.
(F) Overall comparison of DNAmethylation to gene expression. The box plots represent relative gene expression associated with either gain (left) or loss (right) of
methylation in the transition from HSC and MPP1.
(G) Pairwise comparison of DNAmethylation to gene expression. The box plots represent log2 fold change of gene expression associated with either gain or loss
of methylation in the transition from HSC to MPP1. The top 48 anticorrelated genes (24 highest/24 lowest expression in HSCs) are indicated.
(H) Gene expression levels of all members of the HoxB and HoxD clusters.
(I) Relative DNA methylation profile for the HoxB and HoxD clusters. Red arrows indicate examples of DMRs.
See also Figure S5.
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loci. In contrast, the cyclic AMP-mediating cyclic nucleotide
phosphodiesterase 1b (Pde1b), as well as the retinoic acid re-
ceptor orphan receptor g(Rorc), become methylated and down-
regulated during differentiation toward MPP1.
Hox TF clusters are critical during normal and malignant he-
matopoiesis (Argiropoulos and Humphries, 2007), but little is
known about their epigenetic regulation. We found that most
members of the HoxB family showed the highest expression in
HSCs and were associated with DMRs (seven out of nine; Fig-
ures 6H and 6I). Notably, HSC differentiation showed a contin-
uous increase in DMR methylation and paralleled decrease of
RNA expression (Figure 6I, see arrows for Hoxb2 and Hoxb4).
In contrast, the members within the HoxD cluster showed no
specific expression pattern in HSCs and MPPs, and none of its
genes were associated with a DMR (Figure 6I). Similar results
were found for HoxA and HoxC clusters, respectively (Figures
S5G and S5H). In conclusion, the integrated analysis of the
methylome and transcriptome provides a resource of genes
whose expression is, at least partially, regulated by DNAmethyl-
ation and that are possibly involved in the hard wiring of the hier-
archical organization of the HSC/progenitor populations.
Differential lncRNA Expression and the Imprinted Gene
Network in Stem/Progenitors
Long noncoding RNAs (lncRNAs) have been implicated in guid-
ing chromatin remodeling complexes to specific target genes
and mediating gene activation or silencing by recruiting the
DNA demethylation machinery to the promoter (Arab et al.,
2014) or recruiting repressive complexes such as PRC2, respec-
tively (Rinn and Chang, 2012). However, little is known about
their functional role or regulation in stem cells and hematopoiesis
(Paralkar and Weiss, 2013). We identified 682 lncRNAs ex-
pressed in HSC-MPPs, 79 of which were differentially expressed
across all five populations (FDR = 0.1; Figure 7A; Table S2). Un-
supervised clustering (Figure 7B) and pairwise comparisons of
differentially expressed lncRNAs revealed the same population
relationship as using the entire transcriptome data set, again
placing MPP2 between the HSC-MPP1 and the MPP3-MPP4
populations (compare Figures 4E–4G and S6A). Next we clus-
tered the significantly changed lncRNAs based on their relative
expression levels across all populations (Figure 7C; Table S4).
As shown in cluster 2, 12 lncRNAs are strongly expressed in
HSCs compared with the rest of the populations, and none of
these has yet been functionally annotated or studied (e.g.
2410080I02Rik, Gm12474). In addition, 14 lncRNAs are coex-
pressed in HSC-MPP1 (cluster 4), representing additional candi-
dates for regulation of self-renewal (e.g. H19, Malat1, Meg3). In
agreement, the imprinted H19 lncRNA has recently been shown
to mediate HSC quiescence by inhibiting insulin growth factor
(IGF) signaling (Venkatraman et al., 2013). Thirteen lncRNAs
were enriched in MPP3-MPP4, suggesting regulatory roles in
these lineage-restricted populations (cluster 25; e.g. Gm568,
Neat1). AlthoughNeat1 is essential for the integrity of the nuclear
substructure, it has also been linked to the immune response af-
ter HIV-1 infection (Zhang et al., 2013) and might, therefore, be
involved in the maintenance of immune regulatory circuits in
MPP3-MPP4. Notably, most of the differentially expressed
lncRNAs identified here have not been studied in hematopoiesisCeand/or have unknown functions. The lncRNAs H19 and Meg3
that are highly expressed in HSCs compared with MPPs (Fig-
ure 7C, validated by quantitative RT-PCR; Figure S6B) are core
members of the transcriptional imprinted gene network (IGN),
which has been postulated to regulate embryonic growth (Var-
rault et al., 2006). In adult hematopoiesis, the genetic deletion
of several members of this network affects HSC self-renewal
integrity (e.g. Cdkn1c/p57KIP2) (Berg et al., 2011; Rossi et al.,
2012). Therefore, we further investigated the expression of the
IGN members and found an overall strong expression in HSCs
but a steady decrease during the differentiation process (Fig-
ure 7D), suggesting a contribution of the IGN in the maintenance
of self-renewal and/or quiescence of HSCs.
Finally, we interrogated the DMRs within the loci encoding the
682 quantified lncRNAs. This revealed a significant enrichment
of DMRs in the differentially expressed lncRNAs. These DMRs
were enriched within a 10 kb window centered on the transcrip-
tion start site (Figure 7E). A notable example is the H19 locus,
which exhibits a DMR in an enhancer region outside of its
imprinting control region (Figures 7F and 7G). The increasing
level of methylation at this enhancer during the transition from
HSCs toMPPs correlates with decreasing expression during dif-
ferentiation (Figure 7F). Overall, these data suggest that differen-
tial DNA methylation of regulatory regions is a likely mechanism
by which lncRNA expression is controlled in HSCs and their
progeny.
DISCUSSION
In this study, we describe a combined proteome, transcriptome,
and DNA methylome analysis of highly purified primary HSCs
and four downstream MPPs, which we characterized addition-
ally using in vitro and in vivo functional assays (Figure S7). Our
data sets uncover progressively changing cell type-specific
methylation, gene, and protein expression landscapes starting
with quiescent CD34-CD150+CD48-LSK HSCs that sit at the
pinnacle of the hematopoietic hierarchy. These differentiate to-
ward slowly cycling multipotent MPP1, followed bymultipotently
cyclingMPP2. The steady increase in the activity of the cell cycle
and proliferation machinery is paralleled by the robust upregula-
tion of the entire DNA repair machinery. This raises the possibility
that physiological DNA replication in proliferating early progeni-
tors generates significant replicative stress that needs to be
counteracted by the activation of the DNA repair machinery to
ensure genome integrity (Bakker and Passegue´, 2013).
We found that the majority of DMRs either progressively gain
or lose DNAmethylation through early HSC differentiation. More-
over, we observed a global anticorrelation between DNAmethyl-
ation and gene expression. Because this was observed at a
global level by the whole genome DNA methylome analysis
(TWGBS) but not using previous approaches (array-based and
RRBS) (Ji et al., 2010; Bock et al., 2012), our data suggest that
many regulatory regions, including, e.g., distal enhancers critical
for gene expression, are only covered by TWGBS analysis.
The observed high overall correlation between RNA and pro-
tein levels suggests that posttranscriptional regulation is not a
predominant mechanism by which gene expression is regulated
in homeostatic HSCs. However, a small number of specific func-
tions in the stem/progenitor compartment may be regulated inll Stem Cell 15, 507–522, October 2, 2014 ª2014 Elsevier Inc. 517
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Figure 7. Expression Landscape of lncRNAs and the Imprinted Gene Network
(A) Workflow for lncRNA analysis.
(B) Clustering of 79 differentially expressed lncRNAs.
(C) LncRNA expression clusters. Differentially expressed lncRNAs were grouped into 32 clusters based on higher expression (enriched) in one or several cell
population(s) compared to mean expression level across all cell populations. Right, an example diagram for each of the most enriched clusters. Average RNA
expression ± SD is shown.
(D) Expression of imprinted gene network genes.
(E) Differential DNA methylation of quantified lncRNAs. Top panel, comparison of DMRs between differentially and nondifferentially expressed lncRNAs. Bottom
panel, heatmap showing DMRs in red. LncRNAs are ranked by increasing adjusted p value (gray scale). Distances are relative to transcription start sites.
*p = 0.01–0.001; **p < 0.001.
(F) Differential methylation of the lncRNA H19 locus. The H19 locus shows increasing methylation from HSC (red) to MPP1 (blue), MPP2 (green), and MPP3/4
(brown) in two DMRs. The inset shows a diagram depicting average H19 RNA expression (mean ± SD).
(G) Differential methylation of H19 locus at enhancer region 3. Black and white dots represent methylated and unmethylated CpGs, respectively. The red box
indicates DMR.
See also Figure S6.
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scriptional regulation of glycolytic metabolism in HSCs via
Lin28b-Hmga-Igfbp2 signaling (Shyh-Chang and Daley, 2013),
likely because of differences in relative protein synthesis rather
than degradation rate (Kristensen et al., 2013; Signer et al.,
2014). Moreover, our data suggest that HSC self-renewal and
quiescence are regulated by an interplay between the Lin28b-
let7-Hmga-Igfbp2 axis, the IGN regulatory network, and HSC-
enriched pathways such as Wnt and retinoic acid (RA) signaling.
Although some of these pathways are also implicated in embry-
onic HSC emergence from the hemogenic endothelium (Varrault
et al., 2006; Chanda et al., 2013; Copley et al., 2013), the individ-
ual players and mechanisms governing HSC function remain to
be explored in the embryo and in the adult. As an example, the
Lin28b target Igf2bp2 was found to be one of the most differen-
tially expressed transcripts and proteins in HSCs. It is known to
modulate expression of the lncRNA H19, leading to suppression
of proproliferative IGF signaling as well as Let7miRNAs and has
been suggested tomediate HSC quiescence (Runge et al., 2000;
Kallen et al., 2013; Venkatraman et al., 2013). In agreement, our
data show increasing H19 enhancer methylation during the
transition from HSC to MPP1, providing an explanation for the
release of HSCs out of quiescence associated with loss of self-
renewal, which might be enhanced further by suppression of
the IGN activity (i.e. p57; Zou et al., 2011; Tesio and Trumpp,
2011). RA signaling is not only known to be critical for embryonic
HSC emergence (Chanda et al., 2013) but also for the regulation
of Hox gene expression by chromatin reorganization in embry-
onic stem cells (Kashyap et al., 2011). Because we observed
high expression and low DNA methylation of most members of
the HoxA/B clusters in HSCs, it is plausible that RA signaling
contributes to the control of the epigenetic landscape of HoxA/
B transcription factors in HSCs. Moreover, because many Hox
genes are mutated in leukemias, these mechanisms may also
be relevant for leukemic stem cells (Alharbi et al., 2013).
An unexpected finding is the degree of alternatively spliced
transcript isoforms present in HSCs and their progeny. To
date, only rare cases of HSC regulation through alternative
splicing have been reported (Bowman et al., 2006). In this study,
we identified almost 500 genes with alternative transcript iso-
form regulation. Although the underlying regulatory mechanism
remains unknown, the lncRNAMalat1, which is highly expressed
in HSCs, has been suggested to be a regulator of alternative
splicing (Tripathi et al., 2010). In line with this, Malat1 has been
implicated in multiple types of human cancer (Gutschner et al.,
2013), and numerous genetic mutations encoding factors of
the splicing machinery have been detected in patients with
chronic lymphoid leukemia (Martı´n-Subero et al., 2013) andmye-
lodysplastic syndrome, a disease derived directly from HSCs
(Lindsley and Ebert, 2013; Medyouf et al., 2014). Our catalog
of splicing variants, with Foxj3 as an example of an HSC-specific
splice isoform, will serve as a starting point to explore this largely
uncharted area of regulation in HSCs and their immediate prog-
eny. In addition to Malat1, we identified more than 70 differen-
tially expressed lncRNAs, the vast majority of which have no
documented role in hematopoiesis. The variety of molecular
functions assigned to lncRNAs is expanding steadily, and their
biological roles include regulation of genomic imprinting, differ-
entiation, and self-renewal (Fatica and Bozzoni, 2014).CeIn summary, the global signatures for stemness and multipo-
tency generated in this study represent not only a compre-
hensive reference but also suggest distinct areas of stem cell
regulation (progressive DNA methylation, alternative splicing,
and lncRNAs). This study significantly extends the current under-
standing of HSC progenitor biology at the global level and
provides a solid basis for functional studies exploring the net-
works responsible for stem cell quiescence, self-renewal, and
differentiation.
EXPERIMENTAL PROCEDURES
Animals
Eight- to twelve-week-old female C57BL/6 (CD45.2) mice purchased from
Harlan Laboratories and B6.SJL-Ptprca Pepcb/BoyJ (CD45.1) animals pur-
chased from Charles River Laboratories were used throughout the study.
CD45.1/CD45.2 heterozygotes (F1) for transplant auxiliary bone marrow
were bred in-house at the Deutsches Krebsforschungszentrum.
Bone Marrow Reconstitution Experiments
Fifty (HSC, MPP1) or 2,000 cells (HSC, MPP2, MPP3, MPP4) were FACS-
sorted and injected intravenously together with 2 3 105 supportive bone
marrow (BM) cells (CD45.1/2) into lethally irradiated (2 3 450 Gy) (CD45.1)
recipient mice. CD45.2-donor cells were monitored at 1, 3–4, 6, 9, 12, and
16 weeks posttransplantation. For secondary transplantations, whole BM
was isolated at 16 weeks posttransplant, and 1 3 106 cells were retrans-
planted into lethally irradiated CD45.1 recipient mice. Myeloid (CD11b+Gr1+)
and lymphoid (T cells, CD4+CD8+; B cells, B220+) lineages were addressed
by FACS.
Proteomic Analysis
FACS-sorted HSCs and MPP1 (4 3 105) were lysed, and proteins were ex-
tracted, reduced/alkylated, and digested with trypsin. Peptides were labeled
differentially with stable isotope dimethyl labeling on a column as described
previously (Boersema et al., 2009) and fractionated by OFFGEL isoelectric
focusing (Agilent Technologies). In technical duplicates, peptides were sepa-
rated by nanoflow ultra-high-performance liquid chromatography on a
120 min gradient and analyzed by electrospray ionization-tandemmass spec-
trometry (ESI-MS/MS) on a linear trap quadrupole Orbitrap Velos or Orbitrap
Velos Pro (Thermo Fisher Scientific). MS raw data files were processed with
MaxQuant (version 1.3.0.5) (Cox and Mann, 2008). The derived peak list was
searched using the built-in Andromeda search engine (version 1.3.0.5) in
MaxQuant against the Uniprot mouse database (2013.02.20). A 1% FDR
was required at both the protein level and the peptide level. Differential expres-
sion was assessed using the Limma package in R/Bioconductor (Gentleman
et al., 2004; Smyth, 2004), and proteins with an adjusted p value of less than
0.1 were considered expressed differentially between HSC and MPP1.
RNA-seq
Total RNA isolation was performed using an ARCTURUS PicoPure RNA isola-
tion kit (Life Technologies, Invitrogen) according to the manufacturer’s instruc-
tions. Total RNA was used for quality controls and for normalization of the
starting material (Figure S3). cDNA libraries were generated with 10 ng of total
RNA for HSC-MPP using the SMARTer Ultra Low RNA kit for Illumina
sequencing (Clontech Laboratories) according to the manufacturer’s indica-
tions. Sequencing was performed with a HiSeq2000 device (Illumina) and
one sample per lane. Sequenced read fragments were mapped to the mouse
reference genome GRCm38 (ENSEMBL release 69) using the Genomic Short-
Read Nucleotide Alignment program (version 2012-07-20). DESeq2 (Love
et al., 2014) and DEXSeq (Anders et al., 2012) were used to test for differential
expression (FDR = 0.1) and differential exon use, respectively.
TWGBS
DNA methylation analysis using TWGBS (Adey and Shendure, 2012) was
performed as described previously (Wang et al., 2013). Genomic mouse
DNA (10-30 ng) was used as input, and each sequencing library was subjectedll Stem Cell 15, 507–522, October 2, 2014 ª2014 Elsevier Inc. 519
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(Illumina).
Animal procedures were performed according to protocols approved by the
German authorities (Regierungspra¨sidium Karlsruhe [no. Z110/02, DKFZ nos.
261, G175-12, and G140-13]).
ACCESSION NUMBERS
Proteome data have been deposited to the ProteomeXchange Consortium
(http://proteomecentral.proteomexchange.org) via the Proteomics Identifica-
tions Database (PRIDE) partner repository (Vizcaı´no et al., 2013) with the
data set identifier PXD000572. RNA-seq data are available in the ArrayExpress
database (http://www.ebi.ac.uk/arrayexpress) under accession number E-
MTAB-2262. TWGBS data can be accessed under Gene Expression Omnibus
under accession no. GSE52709.
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with this article online at http://dx.doi.org/10.1016/j.stem.2014.07.005.
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